UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):   May 4, 2016

 

GENOMIC HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-51541

 

77-0552594

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

301 Penobscot Drive, Redwood City, California

 

94063

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (650) 556-9300

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 2.02                                            Results of Operations and Financial Condition.

 

On May 4, 2016, Genomic Health, Inc. issued a press release announcing financial results for its first fiscal quarter ended March 31, 2016.  The full text of the press release is furnished as Exhibit 99.1.

 

Item 9.01                                            Financial Statements and Exhibits.

 

(d)                                  Exhibits

 

99.1                         Press release issued by Genomic Health, Inc. dated May 4, 2016.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: May 4, 2016

 

 

 

 

GENOMIC HEALTH, INC.

 

 

 

 

 

By

/s/ G. Bradley Cole

 

Name: G. Bradley Cole

 

Title: Chief Financial Officer

 

3


 

GENOMIC HEALTH, INC.
EXHIBIT INDEX

 

Exhibit 
Number

 

Description

99.1

 

Press release issued by Genomic Health, Inc. dated May 4, 2016

 

4

Genomic Health (NASDAQ:GHDX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Genomic Health Charts.
Genomic Health (NASDAQ:GHDX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Genomic Health Charts.